Likely an opinion/review arguing that traditional clinical semiology is being supplanted by prodromal/neurobiological approaches to neurology, but provides little direct experimental data or actionable therapeutic mechanisms.

Highlights the importance of identifying prodromal signs and biomarkers relevant to early Parkinson's detection and trial enrollment, but the missing abstract and probable conceptual focus limit immediate translational or drug-discovery utility.